In this free webinar, learn why not all technology solutions are interchangeable for decentralized clinical trials (DCTs) and how patient-voice data can help drug developers drive more strategic, fit-for-patient solutions/decisions in clinical trials. Attendees will gain insight into the outcomes of new research on patient impact in decentralized trials and how to optimize DCTs for better outcomes. The featured speakers will discuss why it is important to seek feedback from patients before making strategic operations decisions for clinical trials and to continue to elicit feedback throughout the process.
TORONTO, May 22, 2023 /PRNewswire-PRWeb/ -- Today's clinical trial landscape offers an unprecedented range of decentralized and hybrid options, including home health and community-based options. Digital solutions have been hailed as the path toward more inclusive trials yet many still struggle to recruit representative patient populations, despite clear regulatory guidance. How can the feedback from participants in recent clinical trials help industry refine its decentralized clinical trial (DCT) approach to be even more inclusive and responsive to patient preferences? How can industry work more collaboratively with advocates who possess distinct lines of site into their communities' needs and experiences around trial participation? In this webinar, the featured speakers will explore solutions to maximizing participant engagement in DCTs.
The Patient Choice Centered Research Initiative (PCCRI) asked recent clinical trial participants across a range of patient communities to reflect on their satisfaction with the operational aspects of their trial experience through a 50-question survey. PCCRI then collaborated with five patient advocacy groups with distinct patient population needs to analyze the findings alongside what they've heard from their own communities to turn insights into actionable, feasible DCT strategies that align to patient choice.
This webinar will address how insights from this initiative and other patient-focused efforts can help to close geographic and digital health literacy gaps, decrease trial-related financial toxicities, improve participant engagement and minimize burden for sites and patients.
Register today and learn how incorporating patient insights and preferences into decentralized clinical trials can improve inclusivity and increase participant engagement.
Join Keri McDonough, Head, Patient Voice Consortium, Vice President, Medical & Scientific Strategy, Syneos Health; Nicole Hemmenway, CEO, US Pain Foundation; Michelle M. Ouellette, Associate Director, Site & Patient Experience, Syneos Health; and Sarah Gillespie, Associate Director, Decentralized Clinical Trials, Syneos Health, for the live webinar on Monday, June 12, 2023, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Participant Engagement and Realities in Decentralized Clinical Trials.
ABOUT SYNEOS HEALTH
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically integrating clinical development, medical affairs, and commercial capabilities to address modern market realities.
Together we share insights, use the latest technologies, and apply advanced business practices to speed our customers' delivery of important therapies to patients. We support a diverse, equitable and inclusive culture.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]